OTC · Financial Statements
Antibe Therapeutics Inc. (ATBPF) Financial Statements
$0.22
OTC: ATBPF
Market Cap $11.43M
Overview Financials Dividend Antibe Therapeutics Inc. most recently reported annual revenue of $0, net profit of $-19.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2019 2020 2021 2022 2023 Revenue $10.0M $10.0M $10.0M $0 $0 Operating Profit $-12.0M $-19.0M $-24.0M $-26.0M $-21.0M Net Profit $-13.0M $-19.0M $-26.0M $-25.0M $-19.0M EPS $-0.60 $-0.71 $-0.70 $-0.49 $-0.37 Op Margin -127.8% -192.6% -242.3% — —
Balance Sheet (USD)
Metric 2019 2020 2021 2022 2023 Total Assets $15.0M $14.0M $82.0M $89.0M $71.0M Total Liabilities $7.0M $10.0M $31.0M $32.0M $30.0M Cash $6.0M $6.0M $72.0M $35.0M $7.0M Borrowings $2.0M $2.0M $0 $0 $0
Cash Flow (USD)
Metric 2019 2020 2021 2022 2023 Operating Cash Flow $-7.0M $-12.0M $0 $-17.0M $-16.0M Investing Cash Flow $0 $0 $0 $-20.0M $-12.0M Financing Cash Flow $3.0M $4.0M $-1.0M $0 $0 Net Cash Flow $2.0M $0 $66.0M $-37.0M $-28.0M Free Cash Flow $-7.0M $-12.0M $0 $-17.0M $-16.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.05 EV / EBITDA -0.46 FCF Yield -104.32% Quick Ratio 15.03 Interest Coverage -2568.25 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock